1602O Enucleation prevention and vision preservation in primary uveal melanoma (UM): Preliminary results from a phase II study of neoadjuvant darovasertib.
Saved in:
| Title: | 1602O Enucleation prevention and vision preservation in primary uveal melanoma (UM): Preliminary results from a phase II study of neoadjuvant darovasertib. |
|---|---|
| Authors: | Butler, M.O.1 (AUTHOR), Reichstein, D.2 (AUTHOR), Krema, H.3 (AUTHOR), Mckean, M.4 (AUTHOR), Joshua, A.M.5 (AUTHOR), Lim, L-A.6 (AUTHOR), O'Day, R.7 (AUTHOR), Shackleton, M.8 (AUTHOR), Chandana, S.9 (AUTHOR), Aaberg, T.10 (AUTHOR), Dalvin, L.A.11 (AUTHOR), Angi, M.12 (AUTHOR), Rossi, E.13 (AUTHOR), Correa, Z.14 (AUTHOR), Lutzky, J.15 (AUTHOR), Chao, M.M.16 (AUTHOR), Sachdev, J.C.17 (AUTHOR), Orloff, M.18 (AUTHOR), Beaupre, D.19 (AUTHOR), Shields, C.20 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS947-S948. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.08.2230 |
